chr1-204151840-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018208.4(ETNK2):ā€‹c.13C>Gā€‹(p.Pro5Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00009 in 1,456,316 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000099 ( 0 hom., cov: 32)
Exomes š‘“: 0.000089 ( 0 hom. )

Consequence

ETNK2
NM_018208.4 missense

Scores

1
2
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.05
Variant links:
Genes affected
ETNK2 (HGNC:25575): (ethanolamine kinase 2) The protein encoded by this gene is a member of choline/ethanolamine kinase family which catalyzes the first step of phosphatidylethanolamine (PtdEtn) biosynthesis via the cytidine diphosphate (CDP) ethanolamine pathway. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10781151).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ETNK2NM_018208.4 linkuse as main transcriptc.13C>G p.Pro5Ala missense_variant 1/8 ENST00000367202.9
ETNK2NM_001297760.2 linkuse as main transcriptc.13C>G p.Pro5Ala missense_variant 1/8
ETNK2NM_001297762.2 linkuse as main transcriptc.13C>G p.Pro5Ala missense_variant 1/7
ETNK2NM_001297761.2 linkuse as main transcriptc.-262C>G 5_prime_UTR_variant 1/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ETNK2ENST00000367202.9 linkuse as main transcriptc.13C>G p.Pro5Ala missense_variant 1/81 NM_018208.4 P1Q9NVF9-1
ETNK2ENST00000367201.7 linkuse as main transcriptc.13C>G p.Pro5Ala missense_variant 1/82 Q9NVF9-2

Frequencies

GnomAD3 genomes
AF:
0.0000986
AC:
15
AN:
152098
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000126
AC:
7
AN:
55704
Hom.:
0
AF XY:
0.0000695
AC XY:
2
AN XY:
28762
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000585
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000523
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000889
AC:
116
AN:
1304218
Hom.:
0
Cov.:
31
AF XY:
0.0000849
AC XY:
54
AN XY:
636342
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000201
Gnomad4 ASJ exome
AF:
0.0000534
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000703
Gnomad4 NFE exome
AF:
0.0000971
Gnomad4 OTH exome
AF:
0.000130
GnomAD4 genome
AF:
0.0000986
AC:
15
AN:
152098
Hom.:
0
Cov.:
32
AF XY:
0.000148
AC XY:
11
AN XY:
74300
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000943
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000108
Hom.:
0
Bravo
AF:
0.000140
ExAC
AF:
0.0000528
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 19, 2022The c.13C>G (p.P5A) alteration is located in exon 1 (coding exon 1) of the ETNK2 gene. This alteration results from a C to G substitution at nucleotide position 13, causing the proline (P) at amino acid position 5 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.38
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.026
.;T
Eigen
Benign
-0.40
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.35
N
LIST_S2
Benign
0.76
T;T
M_CAP
Pathogenic
0.68
D
MetaRNN
Benign
0.11
T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.0
N;N
MutationTaster
Benign
0.92
D;N;N
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-0.95
N;N
REVEL
Benign
0.041
Sift
Benign
0.030
D;D
Sift4G
Benign
0.49
T;T
Polyphen
0.10
B;B
Vest4
0.24
MutPred
0.12
Loss of glycosylation at P5 (P = 0.0129);Loss of glycosylation at P5 (P = 0.0129);
MVP
0.51
MPC
0.34
ClinPred
0.018
T
GERP RS
2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.10
gMVP
0.30

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs746714627; hg19: chr1-204120968; API